يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"percutaneous transluminal coronary angioplasty"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    تقرير

    المصدر: Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

  2. 2
    تقرير

    المصدر: Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud System to Heart Failure Monitoring and Reducing Medical Adverse Events.

  3. 3
    تقرير

    المساهمون: Andrzej Tomasik MD PhD FESC, Assistant professor

    المصدر: Frailty Syndrome in Daily Practice of Interventional Cardiology Ward

  4. 4
    تقرير

    المساهمون: Seung-Jung Park, professor, Division of Cardiology, Department of Internal Medicine

    المصدر: Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial

  5. 5
    تقرير

    المساهمون: Duk-Woo Park, MD, professor of medicine

    المصدر: Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease

  6. 6
    تقرير
  7. 7
    تقرير

    المساهمون: Seung-Jung Park, professor of medicine

    المصدر: A Multicenter, Prospective Cohort to Evaluate the Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions

  8. 8
    تقرير

    المصدر: Brak ES, Grantham JA, Rfret S, Wyman RM, Burke MN, Karmpalt D, Lembo N, Pershad A, KandzarDE, Buller CE, DeMartT, LombardWL, Thompson CA. A percutaneous treatment algorhm for crossg coronary chron total occlusns. JACC Cardvasc terv. 2012 Apr;5(4):367-79. do 10.1016/j.jc.2012.02.006.
    Kahn JK. Anggraph suaby for catheter revascularatn of total coronary occlusns patnts from a communy hospal settg. Am Heart J. 1993 Sep;126(3 Pt 1):561-4. do 10.1016/0002-8703(93)90404-w.
    Chrtofferson RD, Lehmann KG, Mart GV, Every N, Caldwell JH, Kapad SR. Effect of chron total coronary occlusn on treatment strategy. Am J Cardl. 2005 May 1;95(9):1088-91. do 10.1016/j.amjcard.2004.12.065.
    Werner GS, Gt AK, Zeymer U, Juenger C, Towae F, Wnbergen H, Senges J. Chron total coronary occlusns patnts wh stable anga pector: pact on therapy and outcome present day clal practe. Cl Res Cardl. 2009 Jul;98(7):435-41. do 10.1007/s00392-009-0013-5. Epub 2009 Mar 18.
    Grantham JA, Jones PG, Cannon L, Spertus JA. Quantyg the early health status benefs of successful chron total occlusn recanalatn: Results from the FlowCard's Approach to Chron Total Occlusn Recanalatn (FACTOR) Trl. Cc Cardvasc Qual Outcomes. 2010 May;3(3):284-90. do 10.1161/CCOUTCOMES.108.825760. Epub 2010 Apr 13.
    Joyal D, Afalo J, Rfret S. Effecteness of recanalatn of chron total occlusns: a systemat revw and meta-analys. Am Heart J. 2010 Jul;160(1):179-87. do 10.1016/j.ahj.2010.04.015.
    SHam-controlled INtErvention to Improve QOL in CTOs: the SHINE CTO Trial

  9. 9
    تقرير

    المصدر: The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness

  10. 10
    تقرير

    المساهمون: G. Rongen, G. Rongen MD PhD

    المصدر: Klean NS. Measurg tropon elevatn after percutaneous coronary terventn: ready for pre te? J Am Coll Cardl. 2006 Nov 7;48(9):1771-3. do 10.1016/j.jacc.2006.08.008. Epub 2006 Oct 17. No abstract avaable.
    ESPR Study Group; Halkes PH, van Gn J, Kappelle LJ, Koudstaal PJ, Algra A. Asp plus dyramole versus asp alone after cerebral chaem of arterl or (ESPR): randomed controlled trl. Lancet. 2006 May 20;367(9523):1665-73. do 10.1016/S0140-6736(06)68734-5. Erratum : Lancet. 2007 Jan 27;369(9558):274.
    Does Pretreatment With Persantin Reduce Periprocedural Troponin-I Release in Patients Undergoing Elective Single Vessel PCI